Background: Neonatal hypoglycemia can cause serious longterm neurodevelopmental outcome. A valid point-of-care glucometer is needed for diagnosis of neonatal hypoglycemia which is in a lower blood glucose range than diabetic patients.
Methods: There were 180 blood specimens included. Nova StatStrip TM and SureStep TM were operated at the bedside immediately after blood drawn. Laboratory tests were done within one hour.
Results:
On average, most of the blood glucose read-outs from Nova StatStrip TM and SureStep TM were higher than laboratory plasma glucose throughout the glucose range with mean differences of 11.2±8.4 mg/dL and 13.7±6.8 mg/dL, respectively. Sensitivity, specificity, positive and negative predictive values were demonstrated. (Table 1 
